Axa’s Twist Bioscience TWST Stock Holding History

Axa’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,400	Closed	-$1.12M	–	1325
2021 Q2	$1.12M	Buy	+8,400	New	+$977K	﹤0.01%	986

Other funds holding TWST

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Axa's TWST Position: Q3 2021 in Review

Axa sold out of Twist Bioscience (TWST) in Q3 2021, closing a stake of 8,400 shares — an estimated $1.12M sold.

Axa first reported a position in TWST in Q2 2021 and held it in 1 quarter. The position peaked at $1.12M in Q2 2021. 235 funds tracked by Wall St. Rank hold TWST as of Q3 2021.

Axa reported no remaining Twist Bioscience position as of Q3 2021 after selling out during the quarter.
Axa sold 8,400 Twist Bioscience shares in Q3 2021, an estimated $1.12M.
Axa first reported a position in Twist Bioscience in Q2 2021 and held it in 1 quarter.
Axa's Twist Bioscience position peaked at $1.12M in Q2 2021.
235 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2021.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.